Regulatory Matters - Volume 31, Issue

Two years into the pandemic outbreak, our lives have changed one way or another. The pandemic not only has impacted our lifestyle, it might also have impacted our career at some level. We might find ourselves needing to venture out onto new paths,…

International teams: How to survive a long-distance work relationship among medical writers - Volume 31, Issue

How does a team of medical writers working in different countries navigate different time zones and cultures to get their work done remotely? In this interview, a team of six medical writers and one editor working at P95, a private research…

Results of the 2021 EMWA salary and compensation survey - Volume 31, Issue

In 2021, EMWA members were asked to participate in a survey about their current salary and compensation. The survey included questions on some of the factors that typically influence earnings, such as education, geographic location, level…

President's Message - Volume 32, Issue

A look forward – and back! - at AI in Medical Writing This issue of Medical Writing is devoted to automation and artificial intelligence (AI), the hot topic that interests all of us and that is likely to change our lives dramatically, at least our…

Medical translation: A driving force behind equitable access to healthcare - Volume 33, Issue

In this Medical Writing issue on Translation, we explore the transformative role of translation in advancing medical communications and improving access to healthcare. Translation is the intricate process of converting the written word from one…

Outgoing President's Message - Volume 33, Issue

Time flies – nothing new in that then! The year of my presidency is finished, so it is time to look back and summarise. It was my first task as a president to introduce a 5-year strategic plan for 2023–2027, and together with the whole Executive…

Publications - Volume 33, Issue

Preprints: Why and how to use them Section Editor and Author: Maddy Dyer Preprints are a key part of science communication and publication strategy. Medical writers should therefore help inform authors about preprint options. In this article, I…

An interview with Research Policy and Initiatives Director Roseline Favresse at the European Organisation for Rare Diseases - Volume 34, Issue

Roseline Favresse is the Research Policy and Initiatives Director at the European Organisation for Rare Diseases (EURORDIS). We interviewed Roseline to learn more about the rare disease landscape within Europe and the exciting recent collaborations…

Celebrating its past, European Medicines Agency looks to the future of public communication - Volume 34, Issue

As the European Medicines Agency (EMA) marks its 30th anniversary with a series of events at its offices in Amsterdam, one area in the spotlight is EMA’s communication with the public. The Agency has made significant strides in this area over the…

Veterinary Medical Writing - Volume 30, Issue

The placebo-by-proxy effect – another argument against homeopathy

Chances are you know about the placebo effect. There are many variables to study,1 but in general, the placebo effect means that if you believe in a positive outcome of a drug, you wi…